1
Nov 9 (Reuters) – Polaryx Therapeutics, Inc: * POLARYX THERAPEUTICS ACTIVATES FIRST CLINICAL TRIAL SITE FOR SOTERIA PHASE 2 BASKET TRIAL OF PLX-200 Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
